Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies - 6 days ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: Harnessing the Power of Tumor-Infiltrating Lymphocytes to Revolutionize Breast Cancer Treatment - 9 days ago SABCS 2024: Using Tumor Immune Profiles to Guide Neoadjuvant Therapy in Young Breast Cancer Patients - 9 days ago Usage of AI With PET/CT Images Could Detect Impacts of Immunotherapy in Lung Cancer - 29 days ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 29 days ago ELA026 Receives Orphan Drug Designation to Treat Hemophagocytic Lymphohistiocytosis - about 2 months ago FDA Grants Regenerative Medicine Advanced Therapy Designation for OBX-115 - 4 months ago Researchers Find Allergy Medication Could Aid Treatment for Lung Cancer - about 1 year ago FDA Approves PD-L1 IHC 22C3 to Identify Gastric or Gastroesophageal Junction Adenocarcinoma - about 1 year ago
3	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 3 months ago
4	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 3 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 3 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 5 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 9 months ago
6	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease - 3 months ago
7	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Medicare Lags, Medicaid Leads for Biosimilar Uptake - 5 months ago Study Confirms: No Great Options for Treating VEXAS - 7 months ago Novel IL-17A Blocker Continues to Impress in PsA - about 1 year ago 'Naked' Gene Therapy Promising for Osteoarthritis - about 1 year ago Bimekizumab Data in axSpA Look Good Through 1 Year - about 1 year ago
8	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Blocking One Protein Extends Lifespan in Mice by Up to 25%, Study Shows - 5 months ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 6 months ago Dupilumab Reduces Airway Inflammation, Mucus Plugs in Asthma Patients - 9 months ago Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma - 12 months ago Biologics Offer New Options in Atopic Dermatitis - about 1 year ago New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing - about 1 year ago
10	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials - 7 months ago

Journalists covering IL10